Sponsor

Northwell Health

Clinical research sponsor

Published trials114
Recruiting shown11
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
MicroRNAs as Biomarkers in First Episode SchizophreniaNCT07703670 · lead sponsor · 2026-07-01
RECRUITING
Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.NCT05148156 · lead sponsor · 2026-02-11
RECRUITING
Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Pilot RCTNCT07254065 · lead sponsor · 2025-11-14
RECRUITING
Cerebellum-based Imaging Neural Markers for Antipsychotic ResponseNCT07483294 · lead sponsor · 2025-11-01
RECRUITING
Optimizing HFrEF Patients Using BaroStim and CardioMemsNCT07399587 · lead sponsor · 2025-01-17
RECRUITING
Biomarkers to Enhance Early Schizophrenia TreatmentNCT06969755 · lead sponsor · 2024-09-04
RECRUITING
iTBS to Enhance Social Cognition in People With PsychosisNCT06118268 · lead sponsor · 2023-04-18
RECRUITING
Tau Networks in Psychotic Alzheimer's DiseaseNCT05847192 · lead sponsor · 2023-04-13
RECRUITING
Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot StudyNCT05389787 · lead sponsor · 2022-08-18
RECRUITING
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk CohortNCT05384535 · lead sponsor · 2022-08-15
RECRUITING
Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis RiskNCT05131035 · lead sponsor · 2021-10-28
RECRUITING
Feasibility of a Diabetes Self-Management Program With Continuous Glucose Monitoring for Adults With Type 2 DiabetesNCT07743307 · lead sponsor · 2026-07-31
ENROLLING_BY_INVITATION
WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCTNCT07250113 · lead sponsor · 2026-02-17
ENROLLING_BY_INVITATION
Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing BlindnessNCT06023927 · lead sponsor · 2025-09-02
NOT_YET_RECRUITING
A BCT Intervention for an Hourly Activity Habit Among Caregivers for Persons With AD/ADRDNCT06801912 · lead sponsor · 2025-03-25
COMPLETED
BCT Intervention For Walking Habit Among Caregivers of People With AD/ADRDNCT06803797 · lead sponsor · 2025-03-18
COMPLETED
Reducing Burden in Care Partners of Community-Dwelling Persons With Dementia and Oropharyngeal DysphagiaNCT06557863 · lead sponsor · 2024-10-08
COMPLETED
Continuous Glucose Monitoring and Behavioral Change Intervention for People With Type 2 Diabetes and Diabetes DistressNCT05941000 · lead sponsor · 2024-09-10
COMPLETED
Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Intervention Development TrialNCT06486922 · lead sponsor · 2024-06-10
COMPLETED
Virtual Personalized Exercise Program for Lung Cancer PatientsNCT06540495 · lead sponsor · 2024-06-03
UNKNOWN
Reduce Loneliness in Care Partners of Persons With AD/ADRDNCT05460494 · lead sponsor · 2024-03-06
COMPLETED
SMART GOALS for Youth With PrediabetesNCT06067451 · lead sponsor · 2023-12-10
UNKNOWN
Eatable Alphabet as a Nutrition Education ToolNCT05166629 · lead sponsor · 2023-09-01
ACTIVE_NOT_RECRUITING
Comparing Post Cardiac Surgery Outcomes in ESRD Patient's With Early Dialysis Versus Standard CareNCT04705701 · lead sponsor · 2021-09-01
WITHDRAWN
Linguistic Predictors of Outcomes in PsychosisNCT05601050 · lead sponsor · 2021-03-04
COMPLETED
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate CancerNCT04656678 · lead sponsor · 2020-11-25
UNKNOWN
Artificial Intelligence to Measure Adherence to Oral MedicationNCT04046497 · lead sponsor · 2020-11-20
UNKNOWN
Ascertaining Diagnosis Classification With Elicited SpeechNCT05601063 · lead sponsor · 2020-10-01
COMPLETED
Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 SurgeNCT04417270 · lead sponsor · 2020-06-12
COMPLETED
Using Digital Media Advertising to Reduce the Duration of Untreated PsychosisNCT03975400 · lead sponsor · 2020-04-22
COMPLETED
Post-operative Complications and Graft Survival With Conventional Versus Continuous Glucose Monitoring in Patients With Diabetes Mellitus Undergoing Renal TransplantationNCT04742023 · lead sponsor · 2020-04-21
COMPLETED
Neural Biomarkers of Electroconvulsive Therapy ResponseNCT04763655 · lead sponsor · 2020-04-01
UNKNOWN
Early-Phase Schizophrenia: Practice-based Research to Improve OutcomesNCT04004364 · lead sponsor · 2020-04-01
UNKNOWN
Feasibility of Using the CGM During TOC From in Persons With T2D Using InsulinNCT04533945 · lead sponsor · 2020-03-25
COMPLETED
Improving Decision-Making for Low Health Literate Prostate CA PatientsNCT05800483 · lead sponsor · 2020-03-01
COMPLETED
Genotypic Influences on Network Progression in Parkinson's DiseaseNCT04228172 · lead sponsor · 2020-02-24
ACTIVE_NOT_RECRUITING
Reducing Behavioral and Psychological Symptoms of Dementia: Family Caregivers (Aim 1)NCT04481568 · lead sponsor · 2020-02-03
COMPLETED
Computational Modeling of 60 Hz Subthalamic Nucleus Deep Brain Stimulation for Gait Disorder in Parkinson's DiseaseNCT04184791 · lead sponsor · 2020-01-15
COMPLETED
Financial Incentives to Improve Medication AdherenceNCT04191876 · lead sponsor · 2019-11-01
COMPLETED
Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)NCT04179721 · lead sponsor · 2019-10-22
COMPLETED
Diabetes Management Program for Hispanic/LatinoNCT03960424 · lead sponsor · 2019-09-30
COMPLETED
PICO Negative Pressure Wound Therapy in Obese Women Undergoing Elective Cesarean Delivery.NCT03414762 · lead sponsor · 2019-04-01
COMPLETED
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PENCT03581877 · lead sponsor · 2019-01-28
ACTIVE_NOT_RECRUITING
Boost rTMS for Auditory Verbal HallucinationsNCT03544333 · lead sponsor · 2018-04-16
TERMINATED
Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and ComorbiditiesNCT03387397 · lead sponsor · 2017-12-12
COMPLETED
The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End ProductsNCT02768220 · lead sponsor · 2017-12-01
WITHDRAWN
Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney DiseaseNCT03383627 · lead sponsor · 2017-11-30
COMPLETED
The CAROLE (CArdiac Related Oncologic Late Effects) StudyNCT03235427 · lead sponsor · 2017-06-27
COMPLETED
Telehealth Pulmonary Rehabilitation for Hispanic and African-American Patients Admitted With Exacerbation of COPDNCT03007485 · lead sponsor · 2017-04-01
COMPLETED
Striatal Connectivity and Clinical Outcome in PsychosisNCT02822092 · lead sponsor · 2016-07-01
COMPLETED
Safety and Tolerability of MSI-1436C in Metastatic Breast CancerNCT02524951 · lead sponsor · 2016-04-01
TERMINATED
A Prospective Trial of BiPAP Administration vs. Non-positive Pressure Therapy for Pediatric Status AsthmaticusNCT02539420 · lead sponsor · 2016-04-01
WITHDRAWN
Adjunctive Vortioxetine in SchizophreniaNCT02357797 · lead sponsor · 2016-02-01
UNKNOWN
Transcranial Direct Current Stimulation for Hallucinations in First-Episode SchizophreniaNCT02661347 · lead sponsor · 2016-02-01
WITHDRAWN
Super-selective Intra-arterial Cerebral Infusion of Trastuzumab for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast CancerNCT02571530 · lead sponsor · 2015-08-01
TERMINATED
The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgitation Spectral Doppler SignalsNCT02560116 · lead sponsor · 2015-06-01
WITHDRAWN
The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging StudyNCT02421146 · lead sponsor · 2015-04-01
COMPLETED
Pleth Variability and Asthma Severity in ChildrenNCT02302261 · lead sponsor · 2015-01-01
COMPLETED
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase PsychosisNCT02566057 · lead sponsor · 2014-07-10
COMPLETED
Telehealth Management in HF Disparity PatientsNCT02196922 · lead sponsor · 2014-01-01
COMPLETED

Sponsor roles

lead sponsor109
collaborator5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.